Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed

Therapeutic plasma exchange and pregnancy: A case report and guidelines for performing plasma exchange in a pregnant patient.
HLA-DRB1*15:01 and multiple sclerosis: a female association?
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
Clinically isolated syndrome - Rethinking the diagnosis.
Episode 39 with Dr. Joseph Berger on diagnostic dilemmas in MS
Environmental, modifiable risk factors for multiple sclerosis
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
T(H)17 cytokines in autoimmune neuro-inflammation.
Keystone Symposium: Neuroepigenetics
The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis.
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID).
Best practice in the use of natalizumab in multiple sclerosis.
Management of worsening multiple sclerosis with mitoxantrone: a review.
Episode 1 with Dr. Timothy Vollmer on maintaining brain health
Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis.
Neuroprotection mediated through estrogen receptor-alpha in astrocytes.
The neuroendocrine axis in patients with multiple sclerosis.
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort.
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair
TECFIDERA prescribing information
Sex differences in autoimmune disease.
Sex differences in autoimmune diseases.
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
Treatment Choices in Optic Neuritis: Corticosteroids, Intravenous Immunoglobulin, Plasma Exchange, or Other?

Pages

« first
‹ previous
…
51
52
53
54
55
56
57
58
59
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By